rdbio (仁度生物 / Rendo Biotech)

Rendo Biotech (仁度生物) is a Shanghai-based molecular diagnostics company founded in 2007 and listed on China's STAR Market (Science and Technology Innovation Board, stock code 688193). It specializes in pathogen RNA clinical detection, developing diagnostic reagents and fully automated nucleic-acid analysis instruments across five clinical areas — reproductive-health screening, bloodborne pathogen detection, respiratory infections, enterovirus identification, and food safety. The company serves 700+ medical institutions and holds 74+ invention patents. It was surfaced as a portfolio company of the Qiming Venture Partners network and added to the API Evangelist network. As of this enrichment pass, Rendo Biotech publishes no public developer API, OpenAPI definition, SDK, or documentation surface — it is a diagnostics-instrument and reagents manufacturer, not an API provider.

rdbio (仁度生物 / Rendo Biotech) is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Molecular Diagnostics, Clinical Diagnostics, and Life Sciences.

🌐 Visit website 📡 Source on GitHub
3.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyBiotechnologyMolecular DiagnosticsClinical DiagnosticsLife SciencesHealthcareRNA DetectionMedical Devices

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 3.3/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/rdbio: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Rdbio Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 1

The organization behind the API

Website
Website

Source (apis.yml)

apis.yml Raw ↑ 
aid: rdbio
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/rdbio.png
name: rdbio (仁度生物 / Rendo Biotech)
description: Rendo Biotech (仁度生物) is a Shanghai-based molecular diagnostics company founded in 2007 and listed on China's
  STAR Market (Science and Technology Innovation Board, stock code 688193). It specializes in pathogen RNA clinical detection,
  developing diagnostic reagents and fully automated nucleic-acid analysis instruments across five clinical areas — reproductive-health
  screening, bloodborne pathogen detection, respiratory infections, enterovirus identification, and food safety. The company
  serves 700+ medical institutions and holds 74+ invention patents. It was surfaced as a portfolio company of the Qiming Venture
  Partners network and added to the API Evangelist network. As of this enrichment pass, Rendo Biotech publishes no public
  developer API, OpenAPI definition, SDK, or documentation surface — it is a diagnostics-instrument and reagents manufacturer,
  not an API provider.
url: https://raw.githubusercontent.com/api-evangelist/rdbio/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- qiming
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Molecular Diagnostics
- Clinical Diagnostics
- Life Sciences
- Healthcare
- RNA Detection
- Medical Devices
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/rdbio-domain-security.yml
- type: Website
  url: https://rdbio.com
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1